SCHEMBL475160

SCHEMBL475160

NCC(S)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8589143 0.88
SCHEMBL25424577 0.82
SCHEMBL21396234 0.76
SCHEMBL8768904 0.76
SCHEMBL14088996 0.76
SCHEMBL1366339 0.74
Hydrochloric Acid SCHEMBL10937460 0.73
SCHEMBL22142804 0.71
SCHEMBL1387493 0.71
SCHEMBL7368734 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046235-A9 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2012-02-23 US claimed
EP-1933878-B1 CONJUGATES OF HYDROXYALKYL STARCH AND AN ACTIVE SUBSTANCE, PREPARED BY CHEMICAL LIGATION VIA THIAZOLIDINE FRESENIUS KABI DE GMBH (DE) 2012-02-01 EP claimed
EP-2279752-A2 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation Fresenius Kabi Deutschland GmbH (DE) 2011-02-02 EP claimed
US-20100311670-A1 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2010-12-09 US claimed
US-20080207562-A1 Conjugates of Hydroxyalkyl Starch and Active Substance, Prepared by Chemical Ligation Via Thiazolidine FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2008-08-28 US claimed
EP-1933878-A2 CONJUGATES OF HYDROXYALKYL STARCH AND AN ACTIVE SUBSTANCE, PREPARED BY CHEMICAL LIGATION VIA THIAZOLIDINE Fresenius Kabi Deutschland GmbH (DE) 2008-06-25 EP claimed
WO-2007031266-A2 CONJUGATES OF HYDROXYALKYL STARCH AND AN ACTIVE SUBSTANCE, PREPARED BY CHEMICAL LIGATION VIA THIAZOLIDINE FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2007-03-22 WO claimed
EP-1762250-A1 Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine Fresenius Kabi Deutschland GmbH (DE) 2007-03-14 EP claimed
EP-1732609-A2 CONJUGATES OF HYDROXYALKYL STARCH AND A PROTEIN Fresenius Kabi Deutschland GmbH (DE) 2006-12-20 EP claimed
WO-2005092391-A2 CONJUGATES OF HYDROXYALKYL STARCH AND A PROTEIN FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2005-10-06 WO claimed
US-20240300997-A1 PROTEIN FOLDING AGENT TOHOKU UNIVERSITY (JP) 2024-09-12 US disclosed
EP-4303224-A1 PROTEIN FOLDING AGENT Tohoku University (JP) 2024-01-10 EP disclosed
WO-2022186243-A1 PROTEIN FOLDING AGENT 国立大学法人東北大学 2022-09-09 WO disclosed
US-20120046235-A9 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2012-02-23 US disclosed
EP-1933878-B1 CONJUGATES OF HYDROXYALKYL STARCH AND AN ACTIVE SUBSTANCE, PREPARED BY CHEMICAL LIGATION VIA THIAZOLIDINE FRESENIUS KABI DE GMBH (DE) 2012-02-01 EP disclosed
EP-1933878-A2 CONJUGATES OF HYDROXYALKYL STARCH AND AN ACTIVE SUBSTANCE, PREPARED BY CHEMICAL LIGATION VIA THIAZOLIDINE Fresenius Kabi Deutschland GmbH (DE) 2008-06-25 EP disclosed
US-20080076700-A1 Method for the Preparation of Oxime, Thiazolidine, Dithiane, Dithiolane, or Hydrazone Linked Analogues of Growth Hormone NOVO NORDISK A/S (DK) 2008-03-27 US disclosed
US-20080076700-A1 Method for the Preparation of Oxime, Thiazolidine, Dithiane, Dithiolane, or Hydrazone Linked Analogues of Growth Hormone NOVO NORDISK A/S (DK) 2008-03-27 US disclosed
WO-2007031266-A2 CONJUGATES OF HYDROXYALKYL STARCH AND AN ACTIVE SUBSTANCE, PREPARED BY CHEMICAL LIGATION VIA THIAZOLIDINE FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2007-03-22 WO disclosed
EP-1762250-A1 Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine Fresenius Kabi Deutschland GmbH (DE) 2007-03-14 EP disclosed